<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We recently reported the translocation of the immunoglobulin (Ig) light chain kappa locus gene with a possible <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene, TFL, in transformed follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the functional significance in cell transformation remains to be elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we first identified two gene products, P58(TFL) and P36(TFL), derived by alternative splicing </plain></SENT>
<SENT sid="3" pm="."><plain>The expression was prominent in <z:mpath ids='MPATH_458'>normal</z:mpath> human lymphocytes but defective in some <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines </plain></SENT>
<SENT sid="4" pm="."><plain>Overexpression of either protein in a mouse pro-B cell line, Ba/F3, and a human <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell line, Jurkat, inhibited G(1) to S phase progression through suppression of <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo> protein (Rb) phosphorylation </plain></SENT>
<SENT sid="5" pm="."><plain>The dominant gene product, P58(TFL), colocalized with <z:chebi fb="2" ids="33699">mRNA</z:chebi>-processing body markers, eukaryotic translation initiation factor 2C and DCP1 decapping-enzyme homolog A, but not with a stress granule maker, T-cell intracellular antigen 1, in the cytoplasm </plain></SENT>
<SENT sid="6" pm="."><plain>Taken together with the unique CCCH-type zinc finger motif, the present study suggests that P58(TFL) could play an important role in the regulation of cell growth through posttranscriptional modification of cell cycle regulators, at least partially, upstream of Rb </plain></SENT>
</text></document>